Know Cancer

or
forgot password

A Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA Values


N/A
18 Years
N/A
Open (Enrolling)
Male
Prostate Cancer

Thank you

Trial Information

A Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA Values


Inclusion Criteria:



- PSA > 4.0 ng/ml

- written informed consent

- age >18

Exclusion Criteria:

- patients with prostate cancer

- patients with prior prostate biopsy

- patients with contraindications against MRI or biopsy

Type of Study:

Interventional

Study Design:

Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Prostate cancer detection rate

Outcome Time Frame:

3 years

Safety Issue:

Yes

Principal Investigator

Christian Arsov, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Department of Urology, University of Duesseldorf

Authority:

Germany: Ethics Commission

Study ID:

002

NCT ID:

NCT01553838

Start Date:

January 2012

Completion Date:

January 2014

Related Keywords:

  • Prostate Cancer
  • prostate biopsy
  • MRI guided biopsy
  • TRUS guided biopsy
  • Prostatic Neoplasms

Name

Location